3月14日，廣東埃納生醫學科技有限公司（以下簡稱“廣東埃納生公司”）董事長陳順俊一行到訪豫資控股集團進行業務交流。中原豫資投資控股集團有限公司（以下簡稱“豫資控股集團”）黨委委員、紀委書記劉慧永出席，豫健生物醫藥集團有限公司（以下簡稱“豫健生物”）總經理崔剛、副總經理董煥杰、河南省領誠基金管理有限公司總經理孫寧等參加座談交流。

劉慧永書記對陳順俊一行到訪表示熱烈歡迎，詳細介紹了豫資控股集團及豫健生物發展歷程、功能定位、產業布局等情況。他表示，為貫徹(che)落實(shi)省(sheng)(sheng)(sheng)委、省(sheng)(sheng)(sheng)政府(fu)部署(shu)，加快(kuai)我省(sheng)(sheng)(sheng)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)醫藥產(chan)業(ye)發(fa)展，在(zai)省(sheng)(sheng)(sheng)政府(fu)國資(zi)(zi)委和省(sheng)(sheng)(sheng)衛(wei)健委的指導下，豫資(zi)(zi)控股集團牽頭組建豫健生(sheng)(sheng)(sheng)物(wu)(wu)(wu)，全面融入“一(yi)(yi)院一(yi)(yi)城一(yi)(yi)產(chan)業(ye)集群(qun)”的建設(she)。豫健生(sheng)(sheng)(sheng)物(wu)(wu)(wu)將作為省(sheng)(sheng)(sheng)內生(sheng)(sheng)(sheng)物(wu)(wu)(wu)醫藥資(zi)(zi)源整合(he)(he)者、產(chan)業(ye)投資(zi)(zi)引領者、創新生(sheng)(sheng)(sheng)態構建者，打造成果轉化、產(chan)業(ye)基地、資(zi)(zi)源整合(he)(he)、資(zi)(zi)本(ben)賦能(neng)“四大平臺”，立(li)足河南(nan)、面向全國，歡(huan)迎像廣東埃納生(sheng)(sheng)(sheng)公司等(deng)優質生(sheng)(sheng)(sheng)物(wu)(wu)(wu)醫藥企業(ye)共(gong)同探討合(he)(he)作機會(hui)，共(gong)謀發(fa)展機遇。

陳順俊(jun)一行認真聽(ting)取了豫資控(kong)(kong)股(gu)集(ji)團(tuan)及(ji)豫健(jian)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物的業(ye)務情況和(he)產(chan)業(ye)發(fa)(fa)展(zhan)戰略，并詳(xiang)細介(jie)紹了廣東(dong)埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)公(gong)(gong)(gong)司(si)的經營情況和(he)產(chan)品研(yan)(yan)發(fa)(fa)進展(zhan)。廣東(dong)埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)醫(yi)學科(ke)技有(you)(you)限公(gong)(gong)(gong)司(si)隸屬于廣東(dong)埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)集(ji)團(tuan)，成(cheng)(cheng)立于2016年，位于廣東(dong)省河(he)(he)源市，控(kong)(kong)股(gu)河(he)(he)南(nan)埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)醫(yi)療(liao)科(ke)技有(you)(you)限公(gong)(gong)(gong)司(si)、重慶埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物工(gong)程有(you)(you)限公(gong)(gong)(gong)司(si)，形成(cheng)(cheng)了一個總部、兩個基地的發(fa)(fa)展(zhan)格局。公(gong)(gong)(gong)司(si)建有(you)(you)IVD檢(jian)驗(yan)試劑(ji)研(yan)(yan)發(fa)(fa)中(zhong)心、微創及(ji)超微內(nei)鏡研(yan)(yan)發(fa)(fa)中(zhong)心、生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物新材料研(yan)(yan)發(fa)(fa)中(zhong)心三個研(yan)(yan)發(fa)(fa)平臺，業(ye)務涉(she)及(ji)麻醉、微創、體外(wai)診斷(duan)、康(kang)復護理、新材料五(wu)大領域，重點(dian)產(chan)品包括麻醉視頻喉鏡、李遜鏡、4K超高(gao)清(qing)內(nei)窺鏡攝像系統(tong)及(ji)電(dian)療(liao)超聲(sheng)治療(liao)儀。陳順俊(jun)表示，廣東(dong)埃(ai)(ai)納(na)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)公(gong)(gong)(gong)司(si)將積極探索(suo)與豫健(jian)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物的合作模式，共同(tong)為雙(shuang)方(fang)業(ye)務拓展(zhan)及(ji)河(he)(he)南(nan)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物醫(yi)藥產(chan)業(ye)高(gao)質量發(fa)(fa)展(zhan)賦能(neng)蓄力。